Description:

E3F05 Second Primary Form NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA

Lien:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA

Mots-clés:

Hirntumoren

D016430

Registration

Central Nervous System Neoplasms

Téléchargé le:

16 juin 2015

DOI:

Pour une demande vous connecter.

Licence :

Creative Commons BY-NC 3.0 Legacy

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

E3F05 Second Primary Form NCT00978458

Détails

INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead

1 Formulaires

StudyEvent: E3F05 Second Primary Form
1. INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead

ECOG clinical trial administrative data

ECOG Protocol Number (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

ECOG Patient ID (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

DCI Name

Registration Step

Reporting Period

Second Primary Cancer (Second Primary)

Patient Initials (Last, First)

Participating Group Protocol Number

Institution/Affiliate

Participating Group Patient ID

Data amendment

Please mark an 'X' if data have been amended. (Please circle amended items in red)

Date data amended (s M D Y)

Second primary cancer assessment

Date of Diagnosis of Second Primary Cancer (M D Y)

Site of Second Primary Cancer

Include information on histologic subtype (s Please attach copies of any corroborating pathology reports)

Briefly describe cancer therapy the patient has received prior to the diagnosis of the second primary and other than that given on ECOG protocols

Briefly describe treatment planned or given for the diagnosis of this second primary

Comments

Investigator Signature

Investigator Signature Date (M D Y)

Retour au début de la page

Similar models

Show recommended models